// Emilie Denicolaï 1 , Emeline Tabouret 1, 2 , Carole Colin 1 , Philippe Metellus 3 , Isabelle Nanni 4 , Celine Boucard 2 , Aurélie Tchoghandjian 1 , David Meyronet 5 , Nathalie Baeza-Kallee 1 , Olivier Chinot 1, 2 , Dominique Figarella-Branger 1, 6 1 Aix-Marseille University, CRO2 UMR 911, Inserm UMR_S 911, Marseille, 13385, France 2 AP-HM, Timone Hospital, Department of Neuro-Oncology, Marseille, 13385, France 3 AP-HM, Timone Hospital, Department of Neuro-Surgery, Marseille, 13385, France 4 AP-HM, North Hospital, Transfer Laboratory, Marseille, 13915, France 5 Hospices Civils de Lyon, Centre de Pathologie et de Neuropathologie Est, Lyon, 69677, France 6 AP-HM, Timone Hospital, Department of Anatomopathology, Marseille, 13385, France Correspondence to: Dominique Figarella-Branger, e-mail: dominique.figarella-branger@univ-amu.fr Keywords: tumor location, glioblastoma, mesenchymal profile, proneural profile Received: July 01, 2015 Accepted: November 20, 2015 Published: November 30, 2015 ABSTRACT Glioblastomas in adults are highly heterogeneous tumors that can develop throughout the brain. To date no predictive-location marker has been identified. We previously derived two glioblastoma cell lines from cortical and periventricular locations and demonstrated distinct transcriptomic profiles. Based on these preliminary results, the aim of this study was to correlate glioblastoma locations with the expression of ten selected genes ( VEGFC , FLT4 , MET , HGF , CHI3L1 , PROM1 , NOTCH1 , DLL3 , PDGFRA , BCAN ). Fifty nine patients with newly diagnosed glioblastomas were retrospectively included. Tumors were classified into cortical and periventricular locations, which were subsequently segregated according to cerebral lobes involved: cortical fronto-parietal (C-FP), cortical temporal (C-T), periventricular fronto-parietal (PV-FP), periventricular temporal (PV-T), and periventricular occipital (PV-O). Gene expression levels were determined using RT-qPCR. Compared to cortical glioblastomas, periventricular glioblastomas were characterized by a higher expression of two mesenchymal genes, VEGFC ( p = 0.001) and HGF ( p = 0.001). Among cortical locations, gene expressions were homogeneous. In contrast, periventricular locations exhibited distinct expression profiles. PV-T tumors were associated with higher expression of two proneural and cancer stem cell genes, NOTCH1 ( p = 0.028) and PROM1 ( p = 0.033) while PV-FP tumors were characterized by high expression of a mesenchymal gene, CHI3L1 ( p = 0.006). Protein expression of NOTCH1 was correlated with RNA expression levels. PV-O glioblastomas were associated with lower expression of VEGFC ( p = 0.032) than other periventricular locations, whereas MET overexpression remained exceptional. These data suggest a differential gene expression profile according to initial glioblastoma location.
No takes yet. Share an insight, caveat, or question.
Denicolaï et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: